Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and cyclophosphamide in pretreated metastatic breast cancer
NCT00589901Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Aug 2006
- Primary completion
- Dec 2008
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, cyclophosphamide in breast cancer, sponsored by Fudan University. Status: unknown.
02
Drugs
capecitabinecyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00589901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589901.